Pfizer Inc.

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 21 Feb 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,250,000€ - 1,499,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

2.5 Fte (5)

Lobbyists with EP accreditation

5

High-level Commission meetings

19

Lobbying Costs over the years

  • Info

    Pfizer Inc.   (PFE)

    EU Transparency Register

    4263301811-33 First registered on 18 Dec 2008

    Goals / Remit

    At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.

    Main EU files targeted

    Revision of general EU pharmaceutical legislation, digital health e.g. European Health Data Space, AI Regulation, gene therapy, pharmaceutical strategy, Paediatric & Orphan Review, Vaccination policy, HTA Regulation, Pharmaceuticals in the Environment, IHI and research programs, EU trade negotiations, corporate tax, Covid-19 vaccines & therapeutics procurement, HERA & bio-preparedness.

    Address

    Head Office
    66 Hudson Boulevard E
    New York NY 10001
    UNITED STATES
    EU Office
    Boulevard de la Plaine 17
    Brussels 1050
    BELGIUM

    Website

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    50%5

    Lobbyists (Full time equivalent)

    2.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    5 accreditations were / are live (in bold) for the selected state of 23 Jul 2024

    Name Start date End Date
    Yordan Aleksandrov 01 Jul 2024 01 Jul 2025
    Coralie DELETTRE 01 Jul 2024 01 Jul 2025
    ANDREA CHIARELLO 29 Jun 2024 29 Jun 2026
    Riccardo ROVERA 15 Jun 2024 15 Jun 2026
    Riccardo ROVERA 17 Jun 2023 15 Jun 2024
    Coralie DELETTRE 30 Jun 2023 29 Jun 2024
    ANDREA CHIARELLO 01 Jul 2023 29 Jun 2024
    Charles FAID 28 Sep 2023 27 Sep 2024
    Yordan Aleksandrov 31 Mar 2023 30 Mar 2024
    Mr Victor DE DECKER 18 Oct 2022 21 Jan 2023
    Charles FAID 09 Sep 2022 08 Sep 2023
    Riccardo ROVERA 01 Jul 2022 17 Jun 2023
    ANDREA CHIARELLO 25 Jun 2022 24 Jun 2023
    Ms Eva GRUT AANDAHL 25 Mar 2022 25 Mar 2023
    Yordan Aleksandrov 24 Mar 2022 24 Mar 2023
    Franjo CAIC 07 Jul 2021 21 Sep 2021
    ANDREA CHIARELLO 06 Jul 2021 25 Jun 2022
    Heike Galbraith 06 Mar 2021 15 Jan 2022
    Ms Eva GRUT AANDAHL 06 Mar 2021 05 Mar 2022
    ANDREA CHIARELLO 14 Aug 2020 06 Jul 2021
    Franjo CAIC 06 Aug 2020 07 Jul 2021
    Ms EVA GRUT AANDAHL 12 Feb 2020 01 Mar 2021
    Charles FAID 12 Feb 2020 01 Mar 2021
    Heike Galbraith 12 Feb 2020 01 Mar 2021
    Mr Matthew Thomas CLAY 14 Dec 2019 12 Dec 2020
    ANDREA CHIARELLO 06 Sep 2019 14 Aug 2020
    Franjo CAIC 22 Aug 2019 06 Aug 2020
    Ms EVA GRUT AANDAHL 06 Feb 2019 12 Feb 2020
    Charles FAID 06 Feb 2019 12 Feb 2020
    Heike Galbraith 06 Feb 2019 12 Feb 2020
    Mr Matthew Thomas CLAY 12 Dec 2018 12 Dec 2019
    ANDREA CHIARELLO 26 Sep 2018 06 Sep 2019
    Ms EVA GRUT AANDAHL 03 Feb 2018 02 Feb 2019
    Charles FAID 03 Feb 2018 02 Feb 2019
    Heike Galbraith 03 Feb 2018 02 Feb 2019
    Mr Matthew Thomas CLAY 09 Jan 2018 12 Dec 2018
    ANDREA CHIARELLO 01 Sep 2017 01 Sep 2018
    Ms EVA GRUT AANDAHL 21 Feb 2017 03 Feb 2018
    Charles FAID 21 Feb 2017 03 Feb 2018
    Heike Galbraith 21 Feb 2017 03 Feb 2018
    Mr Matthew Thomas CLAY 23 Jan 2017 09 Jan 2018
    ANDREA CHIARELLO 30 Sep 2016 01 Sep 2017
    Ms EVA GRUT AANDAHL 10 Mar 2016 22 Feb 2017
    Charles FAID 10 Mar 2016 22 Feb 2017
    Heike Galbraith 10 Mar 2016 22 Feb 2017
    Mr Matthew Thomas CLAY 15 Jan 2016 14 Jan 2017
    ANDREA CHIARELLO 28 Aug 2015 31 Aug 2016
    Ms EVA GRUT AANDAHL 19 Feb 2015 17 Feb 2016
    Charles FAID 25 Feb 2015 18 Feb 2016
    Heike Galbraith 25 Feb 2015 23 Feb 2016
    Mr Matthew Thomas CLAY 09 Jan 2015 07 Jan 2016
    Mr Matthew Thomas CLAY 16 Jan 2014 09 Jan 2015
    Ms EVA GRUT AANDAHL 14 Feb 2013 13 Feb 2014
    Mr Matthew Thomas CLAY 17 Jan 2013 06 Dec 2013
    Mr Matthew Thomas CLAY 20 Dec 2011 08 Feb 2013

    Complementary Information

    5 colleagues are full-time engaged in the Brussels office and spend approx. 50% of their time on activities in scope of the Register.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    In 2023 Pfizer was a member of: EFPIA, Vaccines Europe, EuropaBio, Amcham EU, BusinessEurope, Alliance for Generative Medicine (ARM).

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    1,250,000€ - 1,499,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    fipra 10,000€ - 24,999€
    rpp group 50,000€ - 99,999€
    zn consulting 50,000€ - 99,999€
    evoke incisive health 50,000€ - 99,999€
    fleishman-hillard 50,000€ - 99,999€
    fti consulting 100,000€ - 199,999€

    Intermediaries for current year

    Name
    fti consulting
    rpp group
    fleishman-hillard

    Closed year Costs

    1,250,000€ - 1,499,999€

    Other financial info

    The amount declared in answer (c) includes: relevant percentage of trade associations' work, consultants as declared, percentage of colleagues' fully loaded salary and office expenses.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Pfizer EU website: www.pfizereupolicy.eu

    Pfizer EU Twitter account: @PfizerEUPolicy

    Other activities

    None declared

  • Meetings

    Meetings

    19 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 02 Mar 2023 Location Pfizer, Grange Castle, Clondalkin, Dublin 22
      Subject Introductory meeting
      Cabinet Cabinet of Commissioner Mairead Mcguinness
      Portfolio Financial services, financial stability and Capital Markets Union
      Attending
      • Paul Moley (Cabinet member)
      • Mairead McGuinness (Commissioner)
    • Date 12 Oct 2022 Location Washington, D.C.
      Subject Exchange on-going cooperation; Europe's Beating Cancer plan - exchange on innovation in the future of cancer treatment and care
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      • Tove Ernst (Cabinet member)
    • Date 09 Sep 2022 Location Thessaloniki
      Subject Pharma Strategy
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Margaritis Schinas (Vice-President)
    • Date 26 Nov 2021 Location Videoconference
      Subject Meeting with CEO of Pfizer
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Ursula von der Leyen (President)
    • Date 26 Oct 2021 Location Brussels
      Subject Pharmaceutical sector – trade related issues
      Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis
      Portfolio An Economy that Works for People
      Attending
      • Kevin Keary (Cabinet member)
      • Caroline Boeshertz (Cabinet member)
      • Elina Melngaile (Cabinet member)
      Other Lobbyists
    • Date 18 Oct 2021 Location Phone call
      Subject Call with Pfizer’s Regional President for Vaccines, Mr. Sinan Atlig, to discuss the implementation of COVID-19 vaccines Advance Purchase Agreement
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Giorgios Rossides (Cabinet member)
      • Roberto Reig Rodrigo (Cabinet member)
    • Date 16 Jun 2021 Location online
      Subject Supply chains for medicines
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Margaritis Schinas (Vice-President)
      • Maria Luisa Llano Cardenal (Cabinet member)
      Other Lobbyists
    • Date 07 May 2021 Location Puurs, Belgium
      Subject Site visit and assessment of production capacity and supply chain
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 10 Apr 2021 Location Videocall
      Subject Vaccine production and deliveries
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 07 Apr 2021 Location Brussels
      Subject Vaccine delivery schedule for Q2 2021
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 21 Feb 2021 Location Puurs, Belgium
      Subject COVID-19 vaccines production
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
    • Date 31 Jan 2021 Location Videoconference
      Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Ursula von der Leyen (President)
      Other Lobbyists
    • Date 27 Nov 2018 Location Brussels
      Subject EU-US relations, trade aspects of Brexit
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Nele Eichhorn (Cabinet member)
    • Date 29 Nov 2017 Location Brussels
      Subject Pharmaceutical incentives, antimicrobial resistance
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Vytenis Andriukaitis (Commissioner)
      • Annika Nowak (Cabinet member)
      Other Lobbyists
    • Date 21 Nov 2017 Location Brussels
      Subject Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) and patent research exemptions; innovation in the pharmaceutical industry
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Jyrki Katainen (Vice-President)
      Other Lobbyists
    • Date 01 Sep 2017 Location Cernobbio
      Subject Exchange of views on the Italian and euro zone economies and priorities for reform
      Cabinet Cabinet of Commissioner Pierre Moscovici
      Portfolio Economic and Financial Affairs, Taxation and Customs
      Attending
      • Simon O'Connor (Cabinet member)
      • Pierre Moscovici (Commissioner)
      Other Lobbyists
    • Date 14 Jan 2016 Location Brussels
      Subject AECA Round-Table on “Dealing with Regulatory Burden
      Cabinet Cabinet of First Vice-President Frans Timmermans
      Portfolio Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights
      Attending
      • Bernardus Smulders (Cabinet member)
      Other Lobbyists
    • Date 02 Mar 2015 Location Brussels
      Subject Access to innovative medicine
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
    • Date 27 Jan 2015 Location Brussels Belgium
      Subject Introductory meeting
      Cabinet Cabinet of Commissioner Elżbieta Bieńkowska
      Portfolio Internal Market, Industry, Entrepreneurship and SMEs
      Attending
      • Rolf Carsten Bermig (Cabinet member)
Download this datacard